logo-loader

Nephros receives FDA approval for water filtration device

Published: 10:20 14 Apr 2016 EDT

Water filtration
The S100 is designed to assist hospitals to protect patients from water-borne bacteria.

Med-tech Nephros Inc. (OTCQB:NEPH) has received clearance from the US Food and Drug Administration (FDA) to market its S100 water filtration device.

The S100 ultrafilter is designed to assist hospitals and medical facilities with their efforts to protect patients from water-borne bacteria.

Legionella and Pseudomonas are common bacteria found in water that can have a devastating impact on patients, particularly those with a compromised immune system.

"In response to customer feedback, the S100 adds an end of faucet product to our infection control portfolio to support hospitals in their efforts to protect patients from water-borne pathogens," said chief executive Daron Evans.

"With the 510(k) process completed, we intend to fill initial orders for S100 filters this quarter."

Shares stood at $0.26 at market close Wednesday.

BenevolentAI advances novel ulcerative colitis treatment through Phase 1a trial

BenevolentAI (OTC:BAIVF) chief scientific officer Dr Anne Phelan joins Proactive's Stephen Gunnion with positive safety data from the Phase 1a, first-in-human, clinical study of BEN-8744 in healthy volunteers. Phelan explained that BEN-8744 is a potent, selective PD10 inhibitor, uniquely...

2 hours, 34 minutes ago